ICICIC Securities estimates its specialty chemical coverage universe’s revenue to grow 3.3% YoY in Q4FY23. EBITDA is expected to grow 5.3% YoY; however, excluding Chemplast, we estimate growth to be  15% YoY:  SRF’s EBITDA to dip (-1.4%) YoY on lower margin in non-chemicals, while chemicals business to continue its good show; Navin Fluorine (+98%) to benefit from rise in utilisation of HPP plant and higher specialty / CRAMS revenue; Gujarat Fluorochemicals’ (52% YoY) growth to be led by a strong show in new fluoropolymers and ref-gas, and Clean Science (40% YoY) and EPL (+16% YoY) to benefit from lower input prices. Tatva Chintan’s performance continues to be hurt by higher input cost, while SDA sales to recover. Galaxy Surfactants’ volumes to grow but on low base, but EBITDA/kg may dip. Chemplast’s volumes to be stable; however, PVC spread is likely to recover, but still below mid cycle levels. PCBL’s volumes to grow on re-inventori...